ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,923.20
      -0.80%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.175
      -0.05%
      Bitcoin
      63,452.80
      -1.29%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alnylam Pharmaceuticals Inc (ALNY)

      7. Alnylam Pharmaceuticals Inc (ALNY) News

      ALNY Alnylam Pharmaceuticals Inc

      143.80
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:28:54
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Alnylam Pharmaceuticals Inc ALNY NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 143.80 04:28:54
      Open Price Low Price High Price Close Price Prev Close
      143.80
      more quote information »

      Recent News

      Date Time Source Heading
      4/18/202408:00BWAlnylam to Webcast Conference Call Discussing First Quarter..
      4/07/202408:00BWAlnylam Presents Positive Results from the KARDIA-2 Phase 2..
      3/20/202408:00BWAlnylam to Webcast Investor Event to Discuss Results from..
      3/13/202407:30BWAlnylam Launches Hereditary ATTR (hATTR) Amyloidosis..
      3/06/202406:50BWAlnylam meldet positive KARDIA-2 Topline-Studienergebnisse,..
      3/05/202417:39BWAlnylam annonce des résultats positifs de l’étude KARDIA-2..
      3/05/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202407:30BWAlnylam Reports Positive KARDIA-2 Topline Study Results..
      3/04/202416:33EDGAR2Form 8-K - Current report
      2/29/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202416:00EDGAR2Form 144 - Report of proposed sale of securities
      2/27/202408:30BWAlnylam to Webcast Presentations at Upcoming March Investor..
      2/20/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/20/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/20/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/15/202416:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/15/202408:10EDGAR2Form 8-K - Current report
      2/15/202408:00BWAlnylam Pharmaceuticals Reports Fourth Quarter and Full Year..
      2/09/202418:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/05/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/29/202408:00BWAlnylam to Webcast Conference Call Discussing Fourth Quarter..
      1/19/202416:31EDGAR2Form 8-K - Current report
      1/09/202408:05BWAlnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year..
      1/08/202407:00EDGAR2Form 8-K - Current report
      1/07/202418:00BWAlnylam Announces Preliminary* Fourth Quarter and Full Year..
      1/02/202407:30BWAlnylam to Webcast Presentation at 42nd Annual J.P. Morgan..
      12/29/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/27/202316:03EDGAR2Form 144 - Report of proposed sale of securities
      12/13/202307:30BWAlnylam Highlights Significant Progress with Platform..
      12/11/202316:07EDGAR2Form 144 - Report of proposed sale of securities
      12/06/202308:00BWAlnylam to Webcast Virtual R&D Day
      11/30/202308:00BWAlnylam Ranks #1 on Boston Globe’s Top Places to Work List..
      11/12/202312:08BWAlnylam présente des résultats positifs de l'étude KARDIA-1..
      11/11/202316:00BWAlnylam Presents Positive Results from the KARDIA-1 Phase 2..
      11/07/202308:00BWAlnylam to Webcast Presentations at Upcoming November..
      11/02/202308:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/02/202308:10EDGAR2Form 8-K - Current report
      11/02/202308:00BWAlnylam Pharmaceuticals Reports Third Quarter 2023 Financial..
      10/26/202314:00BWAlnylam Recognized by Science Magazine as Top Employer for..
      10/25/202317:19BWAlnylam Announces Publication of Results from APOLLO-B Phase..
      10/25/202311:05BWAlnylam Reports Additional Positive Interim Phase 1 Results..
      10/19/202308:00BWAlnylam to Webcast Conference Call Discussing Third Quarter..
      10/10/202307:30EDGAR2Form 8-K - Current report
      10/10/202307:02IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations

      Your Recent History

      NASDAQ
      ALNY
      Alnylam Pharmaceuticals
      Delayed Upgrade Clock